Vertex Pharmaceuticals
VRTX
VRTX
386 hedge funds and large institutions have $16.5B invested in Vertex Pharmaceuticals in 2013 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 134 increasing their positions, 161 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
386
Holders Change
-17
Holders Change %
-4.22%
% of All Funds
11.21%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.12%
New
40
Increased
134
Reduced
161
Closed
57
Calls
$388M
Puts
$319M
Net Calls
+$69.6M
Net Calls Change
-$81.1M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$330M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$183M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$136M |
| 4 |
JPMorgan Chase & Co
New York
|
+$115M |
| 5 |
ClearBridge Investments
New York
|
+$75.3M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$246M |
| 2 |
Goldman Sachs
New York
|
-$142M |
| 3 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$128M |
| 4 |
Neuberger Berman Group
New York
|
-$78.8M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$63M |
